Objective.-To identify malaria in US Marines returning from Somalia an
d to determine their compliance with chemoprophylaxis. Design.-Case se
ries. Setting.-The US Navy health care system. Patients.-Consecutive s
ample of 106 US Marines diagnosed with malaria after returning from So
malia in 1993. Main Outcome Measures.-Identification of the incidence
and clinical features of imported malaria. Determination of compliance
with chemoprophylaxis in this cohort. Results.-As of December 20, 199
3, there were 112 cases of imported malaria in 106 US Marine Corps per
sonnel returning from Somalia. Plasmodium vivax accounted for 97 (87%)
of 112 malaria cases, and Plasmodium falciparum accounted for eight (
7%) of 112 cases. Mixed infection with P vivax and P falciparum was no
ted in six (5%) of 112 cases, and a single case of Plasmodium malariae
was identified. Patients with P falciparum malaria were diagnosed a m
ean of 20.9 days (range, 1 to 82 days) after returning to the United S
tates compared with 91.8 days (range, 7 to 228 days) for P vivax infec
tion (P<.0001). The self-reported chemoprophylaxis compliance rate was
56%; however, only 45 (50%) of 90 patients were given an optimal chem
oprophylaxis regimen. Conclusions.-Noncompliance with personal protect
ive measures and chemoprophylaxis contributed to the largest outbreak
of imported malaria in US military personnel since the Vietnam conflic
t. Since military personnel frequently go on leave after deployment, h
ealth care providers throughout the United States must be aware of the
presence of imported malaria from Somalia.